Body recomposition.
Optimize fat loss while building lean muscle. The most studied compound goal in peptide research, with multiple approaches depending on your starting point and timeline.
The Body Recomposition stack.
A balanced protocol engineered for body recomposition via targeted peptide synergy.
3 peptides, precisely sequenced.
Each peptide plays a specific role. Removing any one breaks the synergy.
Tesamorelin
Stimulates GH for fat metabolism. Binds to GHRH receptors on the pituitary gland to stimulate natural growth hormone production, specifically targeting visceral adipose tissue.
BPC-157
Promotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. Acts on multiple repair pathways simultaneously including tendon, ligament, muscle
Ipamorelin
Selective GH secretagogue that mimics ghrelin at the GHS receptor. Does not significantly raise cortisol or prolactin, making it one of the most selective GH-releasing peptides.
Customize this protocol
Open this protocol in the Cycle Planner to adjust duration, swap peptides, and generate your reference dosing chart.
Based on published trial data.
Frequently asked questions.
What is the best peptide stack for body recomposition?
The Tesamorelin + BPC-157 + Ipamorelin stack is the gold standard for body recomp. Tesamorelin drives visceral fat reduction via GH/IGF-1, BPC-157 manages recovery, and Ipamorelin adds clean GH pulses.
How long does a recomp protocol take?
Most protocols run 12 weeks. Measurable body composition changes (DEXA-verified) typically begin at weeks 6-8, with significant results by week 12.
Can I do recomp without peptides?
Yes, but peptides optimize the process. The GH/IGF-1 axis support from Tesamorelin helps preserve lean mass during caloric deficit — the hardest part of natural recomposition.
§ About the Author
Dr. E. Vance
Editorial Director, PeptiDex
Dr. E. Vance is the Editorial Director at PeptiDex and leads the platform's editorial division, ensuring that every published research summary meets rigorous preclinical citation standards. With a Ph.D. in Molecular Pharmacology from Columbia Univers...
View Full Profile